Biotage
announces the launch of the new ISOLUTE® SLE+ 1 mL Supported Liquid
Extraction 48-well plates, enabling the extraction of larger sample
volumes (1 mL total load volume) than presently possible in the
microplate footprint.
Uppsala,
Sweden (June 30, 2014) -- Biotage
(STO: BIOT), a leading global supplier of solutions and technology
for analytical, medicinal and peptide chemistry, announces the launch
of the new ISOLUTE® SLE+ 1 mL Supported Liquid Extraction 48-well
plates, enabling the extraction of larger sample volumes (1 mL total
load volume) than presently possible in the microplate footprint.
The
new ISOLUTE® SLE+ 1 mL sample volume 48-well plates are packed with
ISOLUTE SLE+ material; each well containing sufficient ISOLUTE® SLE+
material to efficiently extract 1 mL of aqueous sample. Existing
96-well formats have a maximum capacity of 400 µL, the new plates
enable customers to extract larger sample volumes and therefore
achieve higher sensitivity, higher throughput and lower detection
limits.
The
new plates are ideal for the extraction of small molecule drugs,
metabolites and endogenous biomarkers from biological fluid samples
prior to analytical techniques such as LC-MS/MS and GC-MS. Analytical
chemists in clinical, forensic toxicology and Pharmacology will
appreciate the high throughput and extra sample capacity.
As
with the other products in the ISOLUTE® SLE+ range, the same simple
load-wait-elute procedure is used with this new 48-well format
reducing method development time.
The
plates can be processed using microplate compatible positive pressure
manifolds, such as the Biotage® Pressure+ 96, vacuum manifolds such
as the Biotage® VacMaster™ 96 and most automated liquid handling
systems.
The
plate is arranged in a 6 x 8 array; with 48 samples being processed
per plate a higher throughput than equivalent column formats is
achievable. A new compatible 48-well collection plate is also
available with a 5 mL capacity so that the entire elution solvent
volume can be collected with no need to swap collection vessels.
For
further information visit http://www.biotage.com
or call:
In
Europe: +46 18 56 57 10
In
North America: (Toll Free) 1 800 446 4752
In
Japan: +81 422 28 1233
Other
areas, please call: +46 18 56 57 10
-Ends-
For
further press information from Biotage please contact:
James
Churchill
Marketing
Communications
Biotage
GB Limited
Distribution
Way
Dyffryn
Business Park
Ystrad
Mynach
Hengoed,
Wales CF82 7TS
United
Kingdom
Tel:
+44 (0)1443 811 849
Mobile:
+44(0)7875484778
E-Mail:
james.churchill@biotage.com
About
Biotage
Biotage
offers solutions, knowledge and experience in the areas of analytical
and medicinal chemistry. Customers include the world's top
pharmaceutical and biotechnology companies, as well as leading
academic institutes. The company is headquartered in Uppsala, Sweden,
with offices in China, Japan, the United Kingdom, the United States
and a worldwide network of distributors. Biotage has 290 employees
with sales of 444.6 MSEK in 2013. Biotage is listed on the NASDAQ OMX
Nordic Stock Exchange. Website: http://www.biotage.com.
